Table 2 Statistical results of IgE variations during VIT
From: Determinants of venom-specific IgE antibody concentration during long-term wasp venom immunotherapy
YJ-IgE levels (kUA/L) | Group | ANOVA | Post-Hoc test | |||||
|---|---|---|---|---|---|---|---|---|
NoS vs SP 0–3 | NoS vs SP 3–5 | SP 0–3 vs SP 3–5 | ||||||
NoS | SP 0–3 | SP 3–5 | F | P | P | P | P | |
(95 % CI) | (95 % CI) | (95 % CI) | ||||||
CAP0 | 5.34 ± 6.26 | 6.27 ± 6.81 | 7.27 ± 7.05 | 1.663 | 0.192 | 1.00 (−3.53; 1.66) | 0.209 (−4.49; 0.62) | 1.00 (−3.65; 1.66) |
CAP3 | 1.91 ± 2.42 | 3.81 ± 4.62 | 2.59 ± 2.80 | 6.261 | 0.002 | 0.002 (−3.20; −0.59) | 0.616 (−1.96; 0.61) | 0.085 (−0.11; 2.55) |
CAP5 | 0.97 ± 1.44 | 1.15 ± 1.17 | 2.13 ± 3.11 | 6.948 | 0.001 | 1.00 (−0.98; 0.63) | 0.002 (−1.95; −0.36) | 0.014 (−1.81; −0.16) |